Anaphylactic shock ke lefu le sa foleng le atileng haholo Europe le Amerika Leboea. Allergy UK e re, hoo e ka bang 20% ea bakuli ba loana le karabelo ea anaphylactic Europe. Anaphylactic shock e hloka hore lisebelisoa tsa adrenaline auto injector li phekoloe. Liente tsa likoloi tsa Adrenaline li rekisoa tlas'a mefuta e fapaneng, joalo ka Emerade, Epipen le Jext UK. Lefatšeng ka bophara 'maraka oa liente tsa likoloi e ne e le boleng ba $ US$ 1,700 Mn, ho latela boleng, ka 2016, ho latela lipatlisiso tsa morao-rao tse entsoeng ke Future Market Insights (FMI). Tlaleho e mabapi le liente tsa likoloi e tsoela pele ho hlahisa kholo ea kholo ka sekhahla sa kholo ea selemo le selemo sa 15.1% ho fihlela 2026.
Li-injection tsa likoloi ke mokhoa o sebetsang oa tsamaiso bakeng sa lithethefatsi tsa intramuscular. Litšobotsi tsa botsoalle tsa liente tsa likoloi li fokotsa moroalo oa ho nka linale le lisyringe tse tloaelehileng. Leha ho le joalo, tlhokomeliso e fokolang mabapi le tšebeliso e nepahetseng ea liente tsa likoloi le theko e phahameng ea lihlahisoa tse tsebahalang ke a mang a lintlha tsa bohlokoa tse thibelang ho amoheloa ha lisebelisoa tsa ente ea likoloi lits'ebetsong tsa tšohanyetso. Ho ipapisitsoe le liphuputso tse entsoeng ke Setsi sa Lipatlisiso sa Setsi sa Bophelo sa Univesithi ea McGill, bakuli ba kulang ba rekang EpiPen bakeng sa ts'ohanyetso ha ba hlile ha ba sebelise sehlahisoa kapele kamoo ba lokelang.
Bakeng sa lintlha tse ling mabapi le 'maraka, kopa mohlala oa sena report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642
Ho feta moo, bakuli ba 'maloa ba etelang lefapha la tšohanyetso ka lebaka la karabelo e matla ea anaphylaxis ba se ba ntse ba tsamaisoa ka epinephrine, ho bolela Journal of Allergy and Clinical Immunology. Ho hloleha ho sebelisa liente tsa likoloi ka nako e nepahetseng haholo-holo ka lebaka la ho hloka tsebo ka matšoao a anaphylaxis. Ho hloka temoho ho joalo ka lefu le sehlahisoa ho baka mathata a bohlokoa, mabapi le ho amoheloa ha lihlahisoa, bakeng sa bahlahisi. Ntle le litheko tse phahameng, bophelo bo fokolang ba shelofo ea pene ea auto-injector & phepelo e tlase ea lihlahisoa (Ex. EpiPen) ke liqholotso tse kholo tse sitisang khetho ea mokuli bakeng sa liente tsa likoloi maemong a tšohanyetso.
Keketseho e ntseng e eketseha ea mahlale a thepa le ts'ebetso ea lisebelisoa tsa li-injector tsa likoloi li tsamaisa katoloso ea 'maraka oa enjene ea likoloi. Ka September 2015, Bayer HealthCare e tlaleha ho qalisoa ha Betaconnect- ente ea elektronike ea koloi bakeng sa phekolo ea relapsing-remitting multiple sclerosis (RRMS). Injector ena ea likoloi e fana ka litekanyetso tse felletseng tsa sethethefatsi bakeng sa ho ntlafatsa melao le ho fokotsa litšenyehelo ka kakaretso. Sehlopha sa SHL se fana ka mefuta e fapaneng ea liente tsa likoloi tse ka amohelang liphetoho tsa liente, joalo ka livolume tse kholoanyane, viscosity e phahameng le tse ling. Baetsi ba li-injector ba shebane le ho ntlafatsa ts'ebetso ea li-injection tsa auto-injection ho ntlafatsa taolo ea mafu le kalafo.
Bakeng sa Boitsebiso ka Mokhoa oa Lipatlisiso o Sebelisitsoeng Tlalehong, Kopa TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1642
Tlholisano e matla 'marakeng oa li-injection tsa likoloi ka lebaka la ketso ea ts'ireletso ea mokuli e thehile tikoloho ea mmaraka ea oligopolistic. Ka lebaka leo, lihlahisoa tse kang EpiPen auto-injector, BD Physioject disposable auto injector, joalo-joalo, li bolokile maemo a tsona 'marakeng. Leha ho le joalo, ho felloa ke nako ha mokuli ha morao tjena le khatello e ntseng e eketseha ho tsoa mekhatlong ea 'muso e tla lebisa ho fokotseheng ha litheko tsa ente ea likoloi, ka hona, ho fokotsa phaello ho baetsi ba mabitso. Li-injection tsa likoloi tsa generic li lebelletsoe ho hlahisa menyetla e phahameng ea kholo bakeng sa batseteli ka lebaka la tšehetso e ntseng e hola ho tsoa ho bafani ba inshorense ea poraefete. Bafani ba lits'ebeletso tsa inshorense ba fokotsa ts'ebetso ea liente tsa likoloi tse theko e phahameng haholo 'me ba koahela lijeneriki tse sa tsoa hlahisoa tse halofo. Kakaretso ea chelete e tsoang ho li-syringe tse tlatsitsoeng esale pele e lebelletsoe ho hola nakong ea kemiso ka lebaka la tlhoko e ntseng e eketseha ea phepelo ea lithethefatsi e reriloeng le e tsitsitseng. Batho ba bacha ba tlameha ho ithuta ka botlalo 'maraka oa Auto Injector hore ba kenelle le ho iphelisa 'marakeng o sa tsotelleng litheko. Boithuto ba boemo ba 'maraka bo tla fana ka leseli mabapi le menyetla ea khoebo
FMI e arotse 'maraka oa lefats'e oa liente tsa likoloi ka mofuta oa sehlahisoa, sesupo, mocha oa kabo le libaka. Mabapi le lekeno, li-injection tsa likoloi tse tlatsitsoeng esale pele li tla ba le karolo e kholo ea mmaraka nakong ea kemiso. Ho fapana le hoo, karolo ea Fillable auto-injection e tla bonts'a menyetla e fokolang ea matsete, ho latela lekeno, ho fihlela 2026.
Tlaleho ena ea FMI e akaretsa tse ling tsa lik'hamphani tsa bohlokoa tse sebetsang 'marakeng oa liente tsa likoloi, tse kang Sanofi, Pfizer, Inc., Becton, Dickinson and Company, Mylan NV, Novartis AG, Janssen Global Services, LLC, Antares Pharma, Amgen Inc. Bayer. AG, & Eli Lilly and Company.
Contact
Nomoro ea Yuniti: 1602-006
Jumeirah Bay 2
Nomoro ea morero: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:
- However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications.
- The global auto injectors market was valued at US$ US$ 1,700 Mn, in terms of value, in 2016, according to the latest research by Future Market Insights (FMI).
- Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market.
